Literature DB >> 28271359

A prospective study on predicting local recurrence of giant cell tumour of bone by evaluating preoperative imaging features of the tumour around the knee joint.

Yifeng He1, Jun Wang2, Ji Zhang1, Fei Yuan3, Xiaoyi Ding4.   

Abstract

PURPOSE: To evaluate the role of medical imaging in predicting local recurrence of giant cell tumour of bone (GCTB) by assessing the preoperative imaging features of GCTB around the knee.
METHODS: Forty-eight consecutive GCTBs in the proximal tibia and distal femur treated with curettage were prospectively enrolled. Patients were grouped in terms of their imaging features on radiography, computed tomography (CT) and magnetic resonance imaging (MRI). All patients were followed up for at least two years after surgery. The association between preoperative imaging features and local recurrence was investigated. Imaging features were retrospectively studied by correlation analysis. The differences between rates were tested by the Chi square and Fisher exact tests; independent factors were determined by multivariate logistic regression analysis.
RESULTS: Cystic change and adjacent soft tissue invasion were associated with a higher rate of local recurrence compared to the negative groups (P < 0.05). Cystic change was identified as an independent risk factor for local recurrence of GCTB (P < 0.05). Expansibility was correlated with the "soap bubble" sign and the fluid-fluid level (P < 0.05); the "soap bubble" sign was correlated with osteosclerosis and the fluid-fluid level (P < 0.05); cortical bone involvement was correlated with adjacent soft tissue invasion (P < 0.05); and cystic change was correlated with the fluid-fluid level (P < 0.05).
CONCLUSION: Cystic change was an independent risk factor for local recurrence of GCTB. Adjacent soft tissue invasion might indirectly relate to local relapse. A cluster of association relationships between imaging features was revealed.

Entities:  

Keywords:  Cystic change; Giant cell tumour of bone; Local recurrence; Medical imaging; Prognostic factor

Mesh:

Year:  2017        PMID: 28271359     DOI: 10.1007/s11547-017-0745-7

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  36 in total

1.  Recurrence in giant cell tumour of bone: imaging features and risk factors.

Authors:  Cheng-Sheng Wang; Jiang-Hua Lou; Jin-Sheng Liao; Xiao-Yi Ding; Lian-Jun Du; Yong Lu; Ling Yan; Ke-Min Chen
Journal:  Radiol Med       Date:  2012-08-08       Impact factor: 3.469

2.  Primary giant cell tumor of soft tissue: fluid-fluid levels at MRI (2010:3b).

Authors:  Ana Rosa Meana Moris; Pedro García Gonzalez; Eduardo Fuente Martin; Carmen Gonzalez Suarez; Luis Moro Barrero
Journal:  Eur Radiol       Date:  2010-04-30       Impact factor: 5.315

3.  Giant cell tumor of long bone: a Canadian Sarcoma Group study.

Authors:  Robert E Turcotte; Jay S Wunder; Marc H Isler; Robert S Bell; Norman Schachar; Bassam A Masri; Guy Moreau; Aileen M Davis
Journal:  Clin Orthop Relat Res       Date:  2002-04       Impact factor: 4.176

Review 4.  Giant cell tumor of bone: review, mimics, and new developments in treatment.

Authors:  Corey J Chakarun; Deborah M Forrester; Christopher J Gottsegen; Dakshesh B Patel; Eric A White; George R Matcuk
Journal:  Radiographics       Date:  2013 Jan-Feb       Impact factor: 5.333

5.  Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years.

Authors:  Aarne H Kivioja; Carl Blomqvist; Kalevi Hietaniemi; Clement Trovik; Anders Walloe; Henrik C F Bauer; Peter H Jorgensen; Peter Bergh; Gunnar Follerås
Journal:  Acta Orthop       Date:  2008-02       Impact factor: 3.717

6.  Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions.

Authors:  S M Kumta; L Huang; Y Y Cheng; L T C Chow; K M Lee; M H Zheng
Journal:  Life Sci       Date:  2003-08-01       Impact factor: 5.037

7.  Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

Authors:  Xiaoyu Jiang; John A Engelbach; Liya Yuan; Jeremy Cates; Feng Gao; Robert E Drzymala; Dennis E Hallahan; Keith M Rich; Robert E Schmidt; Joseph J H Ackerman; Joel R Garbow
Journal:  Clin Cancer Res       Date:  2014-03-19       Impact factor: 12.531

8.  Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).

Authors:  F Gouin; V Dumaine
Journal:  Orthop Traumatol Surg Res       Date:  2013-08-23       Impact factor: 2.256

9.  Expression of ezrin, CD44, and VEGF in giant cell tumor of bone and its significance.

Authors:  Jing Zhang; Jian Dong; Zuozhang Yang; Xiang Ma; Jinlei Zhang; Mei Li; Yun Chen; Yingying Ding; Kun Li; Zhiping Zhang
Journal:  World J Surg Oncol       Date:  2015-05-01       Impact factor: 2.754

10.  Recurrence Rates and Risk Factors for Primary Giant Cell Tumors around the Knee: A Multicentre Retrospective Study in China.

Authors:  Pan Hu; Liming Zhao; Huilin Zhang; Xiuchun Yu; Zhen Wang; Zhaoming Ye; Sujia Wu; Shibing Guo; Guochuan Zhang; Jinghua Wang; Xianjia Ning; Yongcheng Hu; Yingze Zhang
Journal:  Sci Rep       Date:  2016-11-09       Impact factor: 4.379

View more
  7 in total

1.  Prediction of the early recurrence in spinal giant cell tumor of bone using radiomics of preoperative CT: Long-term outcome of 62 consecutive patients.

Authors:  Qizheng Wang; Yang Zhang; Enlong Zhang; Xiaoying Xing; Yongye Chen; Min-Ying Su; Ning Lang
Journal:  J Bone Oncol       Date:  2021-03-16       Impact factor: 4.072

2.  Clinical Significance of Preoperative CT and MR Imaging Findings in the Prediction of Postoperative Recurrence of Spinal Giant Cell Tumor of Bone.

Authors:  Qi-Zheng Wang; En-Long Zhang; Xiao-Ying Xing; Min-Ying Su; Ning Lang
Journal:  Orthop Surg       Date:  2021-11-28       Impact factor: 2.071

3.  Giant Cell Tumors of Bone in Patients Aged 18 Years Old or Younger: Imaging Features and Tumor Characteristics.

Authors:  Xue-Ping Zhang; Xin-Chang Lu; Lin-Lin Wang; Jie-Qin Wei; Jing Yan; Xiao-Ning Shao; Ying-Yu Che; Jing-Liang Cheng
Journal:  Int J Gen Med       Date:  2021-11-18

4.  The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study.

Authors:  Lenian Zhou; Shanyi Lin; Hongyi Zhu; Yang Dong; Qingcheng Yang; Ting Yuan
Journal:  BMC Musculoskelet Disord       Date:  2022-03-03       Impact factor: 2.362

5.  Preoperative CT for prediction of local recurrence after curettage of giant cell tumor of bone.

Authors:  Lenian Zhou; Shanyi Lin; Hanqiang Jin; Zhaoyuan Zhang; Changqing Zhang; Ting Yuan
Journal:  J Bone Oncol       Date:  2021-05-11       Impact factor: 4.072

6.  Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis.

Authors:  Josef Yayan
Journal:  Cancer Control       Date:  2020 Jul-Aug       Impact factor: 3.302

Review 7.  State of the Art and New Concepts in Giant Cell Tumor of Bone: Imaging Features and Tumor Characteristics.

Authors:  Anna Parmeggiani; Marco Miceli; Costantino Errani; Giancarlo Facchini
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.